Event Brief
Dec 10, 2025 at 12:04 AM ET
Fosun Pharma and Pfizer Strike $2.1B Obesity Drug Deal
By The BriefBrief
Pfizer agrees to pay up to $2.1 billion to Fosun Pharma's Yao Pharma for an obesity drug, highlighting trends in global pharma.
WHO: Pfizer, Fosun Pharma, Yao Pharma
WHAT: Licensing agreement for an obesity drug
WHEN: Dec 9, 2025 at 7:00 PM ET
WHERE: Shanghai, China
WHY: To develop and commercialize an experimental obesity drug
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21434 of 21434
Same format. Every time.
Continue reading — sign in or create a free account with
